The balance between MCL-1 and NOXA may determine the susceptibility of cancer cells to drug-induced apoptosis [78], and the degradation of NOXA/MCL-1 complexes has been shown as determining the response of cancer cells to antimitotic treatment [79]. The gene discussed is PMAIP1; the disease is cancer.